CYTOSORBENTS CORPORATION Operating Lease, Liability, Current
CYTOSORBENTS CORPORATION (CTSO) had Operating Lease, Liability, Current of $589.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-06
- 2026-06-30: Operating Lease, Liability, Current $589.00K.
- 2026-03-31: Operating Lease, Liability, Current $565.00K.
- 2025-12-31: Operating Lease, Liability, Current $541.00K.
- 2025-09-30: Operating Lease, Liability, Current $518.00K.
| Period end | Operating Lease, Liability, Current | Operating Lease, Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $589.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $565.00K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $541.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $518.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $495.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $473.89K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $453.00K 10-K · filed 2026-03-30 | $452.69K 10-K · filed 2025-03-31 |
| 2024-09-30 | $432.00K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $412.07K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $392.62K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $373.64K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $117.20K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $114.38K 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $111.63K 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $108.94K 10-K · filed 2024-03-15 | |
| 2022-09-30 | $376.53K 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $416.86K 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $486.96K 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $570.57K 10-K · filed 2023-03-09 | |
| 2021-09-30 | $265.68K 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $251.52K 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $462.90K 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $447.49K 10-K · filed 2022-03-10 | |
| 2020-09-30 | $432.42K 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $417.70K 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $442.87K 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $428.08K 10-K · filed 2021-03-09 | |
| 2019-09-30 | $413.63K 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $399.51K 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $388.92K 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $378.68K 10-K · filed 2020-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |